Free Trial

Brookfield (BN) Financials

Brookfield logo
$65.19 +0.29 (+0.45%)
As of 10:39 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Annual Income Statements for Brookfield

Annual Income Statements for Brookfield

This table shows Brookfield's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders
5,025 7,640 11,392 8,210 -134 3,966 10,390 451 541
Consolidated Net Income / (Loss)
3,338 4,551 7,488 5,354 3,419 12,388 5,195 451 541
Net Income / (Loss) Continuing Operations
3,338 4,551 7,488 5,663 3,419 12,388 7,251 451 541
Total Pre-Tax Income
1,700 3,951 6,152 6,158 4,256 14,712 6,107 -402 -29
Total Operating Income
4,581 5,958 8,046 12,931 10,763 11,615 16,192 -402 -29
Total Gross Profit
6,693 8,398 11,252 17,905 9,441 11,731 16,314 -62 -120
Total Revenue
24,411 40,786 56,771 70,633 62,618 75,731 94,825 -62 -120
Operating Revenue
24,411 40,786 56,771 70,633 62,752 75,731 94,825 -62 -120
Total Cost of Revenue
17,718 32,388 45,519 52,728 53,177 64,000 78,511 0.00 0.00
Total Operating Expenses
2,112 2,440 3,206 4,974 -1,322 116 122 340 -91
Selling, General & Admin Expense
92 95 104 98 101 116 122 5.00 -475
Other Operating Expenses / (Income)
- - - - -1,423 - - 335 384
Total Other Income / (Expense), net
-2,881 -2,007 -1,894 -6,773 -6,507 3,097 -10,085 0.00 0.00
Other Gains / (Losses), net
1,293 1,213 1,088 - - - 2,613 853 570
Basic Earnings per Share
$1.58 - - - - $2.47 - $1.15 $1.31
Weighted Average Basic Shares Outstanding
- 1.37 3.47 1.78 -0.12 - 1.22 391.70M 409.40M
Diluted Earnings per Share
$1.55 $1.34 $3.40 $1.73 ($0.12) $2.39 $1.19 $1.13 $1.28
Weighted Average Diluted Shares Outstanding
- 958.77M 955.14M 1.01B 1.51B - - 396.50M 419.60M
Weighted Average Basic & Diluted Shares Outstanding
- 958.77M 955.14M 1.01B 1.51B - - 413.05M 1.64B
Cash Dividends to Common per Share
- - - - - - - $1.28 $1.52

Quarterly Income Statements for Brookfield

This table shows Brookfield's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q1 2025 Q2 2025
Period end date 3/31/2024 6/30/2024 3/31/2025 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders
441 495 581 620
Consolidated Net Income / (Loss)
373 518 507 584
Net Income / (Loss) Continuing Operations
373 518 507 584
Total Pre-Tax Income
444 660 582 659
Total Operating Income
436 583 579 533
Total Gross Profit
800 956 935 1,074
Total Revenue
861 892 1,048 1,073
Operating Revenue
861 892 1,048 1,073
Total Cost of Revenue
61 -64 113 -1.00
Operating Cost of Revenue
61 -64 113 -1.00
Total Operating Expenses
364 373 356 541
Selling, General & Admin Expense
360 368 343 504
Other Operating Expenses / (Income)
4.00 5.00 13 37
Total Other Income / (Expense), net
8.00 77 3.00 126
Interest & Investment Income
80 53 58 181
Other Income / (Expense), net
-72 24 -55 -55
Income Tax Expense
71 142 75 75
Preferred Stock Dividends Declared
- -6.00 - -99
Net Income / (Loss) Attributable to Noncontrolling Interest
-68 29 -74 63
Basic Earnings per Share
- $0.31 - $0.38
Weighted Average Basic Shares Outstanding
- 1.60B 1.61B 1.61B
Diluted Earnings per Share
- $0.31 - $0.38
Weighted Average Diluted Shares Outstanding
- 1.61B 1.61B 1.63B
Weighted Average Basic & Diluted Shares Outstanding
- - 1.61B 1.61B

Annual Cash Flow Statements for Brookfield

This table details how cash moves in and out of Brookfield's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents
1,519 796 3,462 -1,600 3,166 3,090 1,561 8.00 3.00
Net Cash From Operating Activities
-10,845 4,005 5,159 6,328 -8,341 7,874 8,751 508 627
Net Cash From Continuing Operating Activities
-10,845 4,005 5,159 6,328 8,341 7,874 8,751 508 627
Net Income / (Loss) Continuing Operations
3,338 4,551 7,488 5,354 707 12,388 5,195 451 541
Consolidated Net Income / (Loss)
3,338 4,551 7,488 5,354 707 12,388 5,195 451 541
Non-Cash Adjustments To Reconcile Net Income
33,151 -2,082 -3,254 -2,108 1,985 -8,943 -972 -8.00 218
Changes in Operating Assets and Liabilities, net
-558 -809 -2,177 -1,794 -142 -2,008 -3,155 65 -132
Net Cash From Investing Activities
-10,849 -11,394 -19,833 -36,674 -13,873 -21,045 -39,650 -41 -41
Net Cash From Continuing Investing Activities
-10,849 -11,394 -19,833 -36,674 -13,873 -21,045 -39,650 -41 -41
Other Investing Activities, net
- -1,231 -760 482 -3,585 784 -3,741 -41 -41
Net Cash From Financing Activities
-2,330 8,185 18,136 28,746 8,698 16,261 32,460 -459 -583
Net Cash From Continuing Financing Activities
-2,330 8,082 18,239 28,746 9,100 16,261 32,603 -459 -583
Repurchase of Preferred Equity
- - - - - - - -323 -10
Payment of Dividends
2,796 -5,592 -7,435 -9,340 -7,360 -9,649 -12,131 -505 -630
Issuance of Common Equity
- 256 11 13 0.00 23 14 113 94
Other Financing Activities, net
- 7,193 6,663 16,636 12,719 3,274 10,786 256 -37
Cash Interest Paid
3,062 3,374 4,712 6,323 6,583 7,001 9,009 9.00 16
Cash Income Taxes Paid
371 402 980 504 1,101 1,116 1,079 0.00 0.00

Quarterly Cash Flow Statements for Brookfield

This table details how cash moves in and out of Brookfield's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q1 2025 Q2 2025
Period end date 3/31/2024 6/30/2024 3/31/2025 6/30/2025
Net Change in Cash & Equivalents
-231 -728 -511 390
Net Cash From Operating Activities
516 393 265 378
Net Cash From Continuing Operating Activities
355 327 -173 621
Net Income / (Loss) Continuing Operations
373 518 507 584
Consolidated Net Income / (Loss)
373 518 507 584
Depreciation Expense
4.00 3.00 3.00 11
Non-Cash Adjustments To Reconcile Net Income
156 -92 -358 76
Changes in Operating Assets and Liabilities, net
-178 -102 -325 -50
Net Cash From Investing Activities
-6.00 -452 84 -339
Net Cash From Continuing Investing Activities
-6.00 -452 84 -339
Purchase of Property, Plant & Equipment
-3.00 -124 -2.00 -1.00
Purchase of Investments
0.00 -391 -11 -522
Sale and/or Maturity of Investments
0.00 - 207 30
Other Investing Activities, net
-3.00 63 -116 154
Net Cash From Financing Activities
-580 -603 -422 108
Net Cash From Continuing Financing Activities
-580 -603 -422 108
Payment of Dividends
-622 -659 -710 -710
Issuance of Debt
0.00 - 235 515
Issuance of Common Equity
0.00 - 15 164
Other Financing Activities, net
42 56 154 114
Cash Interest Paid
2.00 7.00 12 38
Cash Income Taxes Paid
91 103 96 32

Annual Balance Sheets for Brookfield

This table presents Brookfield's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets
159,826 192,720 256,281 323,969 343,696 391,003 3,161 3,205 14,157
Total Current Assets
13,432 17,112 25,321 25,247 18,928 34,454 3,161 895 3,387
Cash & Equivalents
4,299 5,139 8,390 6,778 - 12,694 1.00 9.00 404
Accounts Receivable
9,133 11,973 16,931 18,469 18,928 21,760 782 886 2,983
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.00 -193,217 0.00 0.00 0.00 0.00
Total Noncurrent Assets
146,394 175,608 230,960 298,722 318,851 356,549 0.00 2,310 10,770
Long-Term Investments
24,977 31,994 33,647 40,698 41,327 46,100 - - 242
Noncurrent Deferred & Refundable Income Taxes
1,562 1,464 2,732 3,572 3,338 3,340 - - 586
Other Noncurrent Operating Assets
109,567 120,986 164,819 208,690 234,814 244,315 0.00 2,310 9,942
Total Liabilities & Shareholders' Equity
159,826 192,720 256,281 323,969 384,813 391,003 3,161 3,205 14,157
Total Liabilities
90,138 112,848 159,131 207,123 262,171 256,262 784 1,120 2,966
Total Current Liabilities
12,042 19,389 24,801 44,767 243,899 231,626 781 1,120 2,441
Accounts Payable
11,915 17,965 23,989 43,077 50,682 52,546 781 1,120 2,441
Total Noncurrent Liabilities
78,096 93,459 134,330 162,356 18,272 24,636 0.00 0.00 525
Long-Term Debt
64,891 78,389 118,218 143,375 - - - - 0.00
Noncurrent Deferred & Payable Income Tax Liabilities
9,640 11,409 12,236 14,849 15,913 20,328 - - 46
Other Noncurrent Operating Liabilities
3,565 3,661 3,876 4,132 - 4,308 - - 479
Redeemable Noncontrolling Interest
- - - - - - - - 2,103
Total Equity & Noncontrolling Interests
69,688 79,872 97,150 116,846 122,642 134,741 2,377 2,085 9,088
Total Preferred & Common Equity
26,453 79,872 97,150 116,846 122,642 134,741 2,377 2,076 8,752
Total Common Equity
26,453 79,872 97,150 116,846 122,642 134,741 2,377 2,076 8,752
Common Stock
26,453 - - - - - 2,688 2,757 9,169
Retained Earnings
- - - - - - 19 -35 -488
Accumulated Other Comprehensive Income / (Loss)
- - - - - - 0.00 3.00 162
Other Equity Adjustments
- 79,872 97,150 116,846 - - -330 - -91
Noncontrolling Interest
43,235 - - - - - 0.00 9.00 336

Quarterly Balance Sheets for Brookfield

This table presents Brookfield's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q4 2022 Q4 2023 Q4 2024 Q1 2025 Q2 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 3/31/2025 6/30/2025
Total Assets
441,284 490,095 490,424 14,966 16,143
Total Current Assets
41,774 39,734 45,269 4,164 4,398
Cash & Equivalents
14,396 11,222 15,051 332 480
Accounts Receivable
27,378 28,512 30,218 3,832 3,918
Plant, Property, & Equipment, net
0.00 0.00 0.00 0.00 0.00
Total Noncurrent Assets
399,510 450,361 445,155 10,802 11,745
Long-Term Investments
47,094 59,124 68,310 422 744
Noncurrent Deferred & Refundable Income Taxes
3,403 3,338 3,723 613 647
Other Noncurrent Operating Assets
279,110 311,505 291,029 9,767 10,354
Total Liabilities & Shareholders' Equity
441,284 490,095 490,424 14,966 16,143
Total Liabilities
299,393 321,853 325,041 4,073 5,113
Total Current Liabilities
57,941 59,011 60,223 3,035 3,347
Accounts Payable
57,065 58,893 55,502 3,035 3,347
Total Noncurrent Liabilities
241,452 262,842 264,818 1,038 1,766
Long-Term Debt
214,074 233,710 234,792 235 743
Noncurrent Deferred & Payable Income Tax Liabilities
23,190 24,987 25,267 97 114
Other Noncurrent Operating Liabilities
4,188 4,145 4,759 706 909
Redeemable Noncontrolling Interest
- - - 1,930 1,859
Total Equity & Noncontrolling Interests
141,891 168,242 165,383 8,963 9,171
Total Preferred & Common Equity
141,891 168,242 165,383 8,489 8,470
Total Common Equity
141,891 168,242 165,383 8,489 8,470
Common Stock
- - - 9,150 9,209
Retained Earnings
- - - -617 -715
Accumulated Other Comprehensive Income / (Loss)
- - - 176 196
Other Equity Adjustments
141,891 168,242 165,383 -220 -220
Noncontrolling Interest
- - - 474 701

Annual Metrics And Ratios for Brookfield

This table displays calculated financial ratios and metrics derived from Brookfield's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics
- - - - - - - - -
Revenue Growth
0.00% 67.08% 39.19% 24.42% -11.35% 20.94% 25.21% 0.00% -93.55%
EBITDA Growth
0.00% 42.44% 42.45% 29.44% -5.05% 51.69% -6.88% 0.00% 92.79%
EBIT Growth
0.00% 53.23% 45.60% 21.62% -13.72% 72.02% -15.38% 0.00% 92.79%
NOPAT Growth
0.00% -8.66% 66.29% 42.07% -27.29% 13.11% 25.73% 0.00% 92.79%
Net Income Growth
0.00% 36.34% 64.54% -28.50% -36.14% 262.33% -58.06% 0.00% 19.96%
EPS Growth
0.00% -13.55% 153.73% -28.50% -36.14% 262.33% -50.21% 0.00% 13.27%
Operating Cash Flow Growth
0.00% 136.93% 28.81% 22.66% -231.81% 194.40% 11.14% 0.00% 23.43%
Free Cash Flow Firm Growth
0.00% 0.00% -290.65% 36.48% 775.47% -207.49% 81.11% 0.00% 0.00%
Invested Capital Growth
0.00% 15.19% 42.18% 22.67% -82.63% 563.40% 20.34% 0.00% 57.32%
Revenue Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EBIT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Income Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Profitability Metrics
- - - - - - - - -
Gross Margin
27.42% 20.59% 19.82% 25.35% 15.08% 15.49% 17.20% 0.00% 0.00%
EBITDA Margin
28.48% 24.28% 24.85% 25.85% 27.69% 34.73% 25.83% 0.00% 0.00%
Operating Margin
18.77% 14.61% 14.17% 18.31% 17.19% 15.34% 17.08% 0.00% 0.00%
EBIT Margin
20.21% 18.53% 19.39% 18.95% 18.44% 26.23% 17.73% 0.00% 0.00%
Profit (Net Income) Margin
13.67% 11.16% 13.19% 7.58% 5.46% 16.36% 5.48% 0.00% 0.00%
Tax Burden Percent
196.35% 115.19% 121.72% 86.94% 80.33% 84.20% 85.07% -112.19% -1,865.52%
Interest Burden Percent
34.46% 52.27% 55.90% 46.01% 36.85% 74.06% 36.33% 100.00% 100.00%
Effective Tax Rate
-20.29% 15.52% -4.03% 8.04% 19.67% 15.80% 24.05% 0.00% 0.00%
Return on Invested Capital (ROIC)
5.25% 4.46% 5.72% 6.21% 6.98% 6.99% 4.59% 0.00% 0.00%
ROIC Less NNEP Spread (ROIC-NNEP)
-0.90% 3.19% 4.19% -1.53% -122.32% 30.35% -0.89% 0.00% 0.00%
Return on Net Nonoperating Assets (RNNOA)
-0.46% 1.63% 2.74% -1.21% -4.13% 2.63% -0.84% 0.00% 0.00%
Return on Equity (ROE)
4.79% 6.09% 8.46% 5.00% 2.86% 9.63% 3.76% 20.22% 20.18%
Cash Return on Invested Capital (CROIC)
0.00% -9.66% -29.12% -14.15% 147.79% -140.61% -13.87% 0.00% -45.31%
Operating Return on Assets (OROA)
3.09% 4.29% 4.90% 4.61% 3.46% 5.41% 4.04% 0.00% 0.00%
Return on Assets (ROA)
2.09% 2.58% 3.34% 1.85% 1.02% 3.37% 1.25% 0.00% 0.00%
Return on Common Equity (ROCE)
1.82% 4.33% 8.46% 5.00% 2.86% 9.63% 3.76% 20.17% 20.02%
Return on Equity Simple (ROE_SIMPLE)
12.62% 5.70% 7.71% 4.58% 2.79% 9.19% 3.66% 21.72% 16.66%
Net Operating Profit after Tax (NOPAT)
5,511 5,034 8,370 11,892 8,646 9,780 12,297 -281 -20
NOPAT Margin
22.57% 12.34% 14.74% 16.84% 13.81% 12.91% 12.97% 0.00% 0.00%
Net Nonoperating Expense Percent (NNEP)
6.15% 1.26% 1.52% 7.74% 129.31% -23.36% 5.49% 8,137.78% 5,345.71%
Return On Investment Capital (ROIC_SIMPLE)
4.09% 3.18% 3.89% 4.57% 2.74% 3.15% 3.45% -13.50% -0.62%
Cost of Revenue to Revenue
72.58% 79.41% 80.18% 74.65% 84.92% 84.51% 82.80% 0.00% 0.00%
SG&A Expenses to Revenue
0.38% 0.23% 0.18% 0.14% 0.16% 0.15% 0.13% 0.00% 0.00%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
8.65% 5.98% 5.65% 7.04% -2.11% 0.15% 0.13% 0.00% 0.00%
Earnings before Interest and Taxes (EBIT)
4,933 7,559 11,006 13,385 11,548 19,865 16,809 -402 -29
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
6,953 9,904 14,108 18,261 17,339 26,302 24,492 -402 -29
Valuation Ratios
- - - - - - - - -
Price to Book Value (P/BV)
0.00 0.26 0.19 0.25 0.39 0.58 0.36 7.64 6.84
Price to Tangible Book Value (P/TBV)
0.00 0.34 0.27 0.40 0.58 0.93 0.68 7.64 6.84
Price to Revenue (P/Rev)
0.00 0.51 0.33 0.42 0.77 1.03 0.54 0.00 0.00
Price to Earnings (P/E)
0.00 2.72 1.62 3.62 0.00 19.72 4.88 35.18 41.05
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 3.33% 2.83%
Earnings Yield
0.00% 36.81% 61.67% 27.63% 0.00% 5.07% 20.48% 2.84% 2.44%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.51 0.55 0.60 5.47 0.80 0.70 7.64 6.81
Enterprise Value to Revenue (EV/Rev)
0.00 1.52 1.67 1.78 3.20 2.58 2.14 0.00 0.00
Enterprise Value to EBITDA (EV/EBITDA)
0.00 6.26 6.71 6.88 11.55 7.43 8.30 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)
0.00 8.20 8.60 9.38 17.34 9.83 12.10 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 12.32 11.31 10.56 23.16 19.98 16.53 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 15.48 18.35 19.85 0.00 24.81 23.23 31.23 35.45
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00 1.09 0.00 0.00 0.00 0.00
Leverage & Solvency
- - - - - - - - -
Debt to Equity
0.93 0.98 1.22 1.23 1.58 1.31 1.51 0.00 0.00
Long-Term Debt to Equity
0.93 0.98 1.22 1.23 0.00 0.00 1.51 0.00 0.00
Financial Leverage
0.51 0.51 0.65 0.79 0.03 0.09 0.94 0.00 0.00
Leverage Ratio
2.29 2.36 2.54 2.71 2.79 2.85 3.01 1.43 1.42
Compound Leverage Factor
0.79 1.23 1.42 1.25 1.03 2.11 1.09 1.43 1.42
Debt to Total Capital
48.22% 49.53% 54.89% 55.10% 61.17% 56.63% 60.14% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 61.17% 56.63% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
48.22% 49.53% 54.89% 55.10% 0.00% 0.00% 60.14% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
32.13% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.43% 0.95%
Common Equity to Total Capital
19.66% 50.47% 45.11% 44.90% 38.83% 43.37% 39.86% 99.57% 99.05%
Debt to EBITDA
9.33 7.91 8.38 7.85 11.14 6.69 8.74 0.00 0.00
Net Debt to EBITDA
5.12 4.17 5.40 5.25 8.76 4.45 6.23 0.00 0.00
Long-Term Debt to EBITDA
9.33 7.91 8.38 7.85 0.00 0.00 8.74 0.00 0.00
Debt to NOPAT
11.78 15.57 14.12 12.06 22.35 17.99 17.41 0.00 0.00
Net Debt to NOPAT
6.46 8.20 9.10 8.06 17.57 11.98 12.41 0.00 0.00
Long-Term Debt to NOPAT
11.78 15.57 14.12 12.06 0.00 0.00 17.41 0.00 0.00
Altman Z-Score
0.00 0.44 0.44 0.37 -0.38 -0.06 0.40 7.97 11.90
Noncontrolling Interest Sharing Ratio
62.04% 28.91% 0.00% 0.00% 0.00% 0.00% 0.00% 0.20% 0.75%
Liquidity Ratios
- - - - - - - - -
Current Ratio
1.12 0.88 1.02 0.56 0.08 0.15 0.72 0.80 0.88
Quick Ratio
1.12 0.88 1.02 0.56 0.08 0.15 0.72 0.80 0.88
Cash Flow Metrics
- - - - - - - - -
Free Cash Flow to Firm (FCFF)
0.00 -10,915 -42,641 -27,083 182,939 -196,649 -37,155 0.00 -1,210
Operating Cash Flow to CapEx
0.00% 481.37% 0.00% 137.71% -123.90% 70.15% 70.40% 0.00% 0.00%
Free Cash Flow to Firm to Interest Expense
0.00 -3.03 -8.78 -3.75 25.36 -38.16 -3.47 0.00 0.00
Operating Cash Flow to Interest Expense
-3.35 1.11 1.06 0.88 -1.16 1.53 0.82 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
-2.88 0.88 1.12 0.24 -2.09 -0.65 -0.34 0.00 0.00
Efficiency Ratios
- - - - - - - - -
Asset Turnover
0.15 0.23 0.25 0.24 0.19 0.21 0.23 0.00 0.00
Accounts Receivable Turnover
2.67 3.86 3.93 3.99 3.35 3.72 3.86 0.00 0.00
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Accounts Payable Turnover
1.49 2.17 2.17 1.57 1.13 1.24 1.43 0.00 0.00
Days Sales Outstanding (DSO)
136.56 94.44 92.92 91.47 108.99 98.05 94.57 0.00 0.00
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
245.46 168.37 168.21 232.13 321.77 294.36 254.79 0.00 0.00
Cash Conversion Cycle (CCC)
-108.90 -73.93 -75.29 -140.66 -212.78 -196.31 -160.22 0.00 0.00
Capital & Investment Metrics
- - - - - - - - -
Invested Capital
104,998 120,947 171,958 210,933 36,640 243,069 292,521 2,076 3,266
Invested Capital Turnover
0.23 0.36 0.39 0.37 0.51 0.54 0.35 0.00 0.00
Increase / (Decrease) in Invested Capital
0.00 15,949 51,011 38,975 -174,293 206,429 49,452 0.00 1,190
Enterprise Value (EV)
0.00 62,010 94,654 125,611 200,290 195,365 203,323 15,865 22,228
Market Capitalization
0.00 20,754 18,473 29,712 48,400 78,227 50,739 15,865 22,209
Book Value per Share
$0.00 $58,300,729,927.01 $101.33 $122.33 $121.89 $89.19 $116,304,098,360.66 $5.04 $7.86
Tangible Book Value per Share
$0.00 $44,024,087,591.24 $72.56 $78.09 $82.76 $55.54 $61,326,229,508.20 $5.04 $7.86
Total Capital
134,579 158,261 215,368 260,221 315,859 310,673 355,965 2,085 3,278
Total Debt
64,891 78,389 118,218 143,375 193,217 175,932 214,074 0.00 0.00
Total Long-Term Debt
64,891 78,389 118,218 143,375 0.00 0.00 214,074 0.00 0.00
Net Debt
35,615 41,256 76,181 95,899 151,890 117,138 152,584 -9.00 -12
Capital Expenditures (CapEx)
-1,537 832 -257 4,595 6,732 11,225 12,431 0.00 0.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
-2,909 -7,416 -7,870 -26,298 -31,754 -33,934 -30,563 -234 -140
Debt-free Net Working Capital (DFNWC)
1,390 -2,277 520 -19,520 -31,754 -21,240 -16,167 -225 -128
Net Working Capital (NWC)
1,390 -2,277 520 -19,520 -224,971 -197,172 -16,167 -225 -128
Net Nonoperating Expense (NNE)
2,173 483 882 6,538 5,227 -2,608 7,102 -732 -561
Net Nonoperating Obligations (NNO)
35,310 41,075 74,808 94,087 -86,002 108,328 150,630 -9.00 -12
Total Depreciation and Amortization (D&A)
2,020 2,345 3,102 4,876 5,791 6,437 7,683 0.00 0.00
Debt-free, Cash-free Net Working Capital to Revenue
-11.92% -18.18% -13.86% -37.23% -50.71% -44.81% -32.23% 0.00% 0.00%
Debt-free Net Working Capital to Revenue
5.69% -5.58% 0.92% -27.64% -50.71% -28.05% -17.05% 0.00% 0.00%
Net Working Capital to Revenue
5.69% -5.58% 0.92% -27.64% -359.28% -260.36% -17.05% 0.00% 0.00%
Earnings Adjustments
- - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $1.11 $0.00 $0.00 $0.00 $0.00 $1.22 $1.15 $1.31
Adjusted Weighted Average Basic Shares Outstanding
0.00 1.18B 4.00 3.00 0.00 3.00 0.00 391.70M 409.40M
Adjusted Diluted Earnings per Share
$0.00 $1.09 $2.77 $2.12 ($0.10) $1.94 $1.19 $1.13 $1.28
Adjusted Weighted Average Diluted Shares Outstanding
0.00 1.18B 1.17B 1.24B 1.86B 0.00 0.00 396.50M 419.60M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 1.18B 1.17B 1.24B 1.86B 0.00 0.00 413.05M 1.64B
Normalized Net Operating Profit after Tax (NOPAT)
3,207 5,034 5,632 11,892 8,646 9,780 12,297 -281 -20
Normalized NOPAT Margin
13.14% 12.34% 9.92% 16.84% 13.81% 12.91% 12.97% 0.00% 0.00%
Pre Tax Income Margin
6.96% 9.69% 10.84% 8.72% 6.80% 19.43% 6.44% 0.00% 0.00%
Debt Service Ratios
- - - - - - - - -
EBIT to Interest Expense
1.53 2.10 2.27 1.85 1.60 3.86 1.57 0.00 0.00
NOPAT to Interest Expense
1.70 1.40 1.72 1.65 1.20 1.90 1.15 0.00 0.00
EBIT Less CapEx to Interest Expense
2.00 1.86 2.32 1.22 0.67 1.68 0.41 0.00 0.00
NOPAT Less CapEx to Interest Expense
2.18 1.16 1.78 1.01 0.27 -0.28 -0.01 0.00 0.00
Payout Ratios
- - - - - - - - -
Dividend Payout Ratio
-83.76% 122.87% 99.29% 174.45% 215.27% 77.89% 233.51% 111.97% 116.45%
Augmented Payout Ratio
-83.76% 125.75% 104.71% 179.73% 215.27% 80.86% 246.72% 111.97% 116.45%

Quarterly Metrics And Ratios for Brookfield

This table displays calculated financial ratios and metrics derived from Brookfield's official financial filings.

Metric Q1 2024 Q2 2024 Q1 2025 Q2 2025
Period end date 3/31/2024 6/30/2024 3/31/2025 6/30/2025
Growth Metrics
- - - -
Revenue Growth
0.00% 0.00% 21.72% 20.29%
EBITDA Growth
0.00% 0.00% 43.21% -19.84%
EBIT Growth
0.00% 0.00% 43.96% -21.25%
NOPAT Growth
0.00% 0.00% 37.71% 3.23%
Net Income Growth
0.00% 0.00% 35.92% 12.74%
EPS Growth
0.00% 0.00% 0.00% 22.58%
Operating Cash Flow Growth
0.00% 0.00% -48.64% -3.82%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00%
Invested Capital Growth
0.00% 0.00% 0.00% 0.00%
Revenue Q/Q Growth
0.00% 3.60% 0.00% 2.39%
EBITDA Q/Q Growth
0.00% 65.76% 0.00% -7.21%
EBIT Q/Q Growth
0.00% 66.76% 0.00% -8.78%
NOPAT Q/Q Growth
0.00% 24.92% 0.00% -6.35%
Net Income Q/Q Growth
0.00% 38.87% 0.00% 15.19%
EPS Q/Q Growth
0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth
0.00% -23.84% 0.00% 42.64%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% -2.10%
Invested Capital Q/Q Growth
0.00% 0.00% 0.00% 1.69%
Profitability Metrics
- - - -
Gross Margin
92.92% 107.17% 89.22% 100.09%
EBITDA Margin
42.74% 68.39% 50.29% 45.57%
Operating Margin
50.64% 65.36% 55.25% 49.67%
EBIT Margin
42.28% 68.05% 50.00% 44.55%
Profit (Net Income) Margin
43.32% 58.07% 48.38% 54.43%
Tax Burden Percent
84.01% 78.48% 87.11% 88.62%
Interest Burden Percent
121.98% 108.73% 111.07% 137.87%
Effective Tax Rate
15.99% 21.52% 12.89% 11.38%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.62% 2.07%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% -0.39% -44.36%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.02% 1.93%
Return on Equity (ROE)
0.00% 0.00% 0.64% 4.00%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.00%
Operating Return on Assets (OROA)
0.00% 0.00% 0.22% 0.68%
Return on Assets (ROA)
0.00% 0.00% 0.22% 0.84%
Return on Common Equity (ROCE)
0.00% 0.00% 0.50% 3.07%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 7.95% 0.00%
Net Operating Profit after Tax (NOPAT)
366 458 504 472
NOPAT Margin
42.54% 51.30% 48.13% 44.02%
Net Nonoperating Expense Percent (NNEP)
0.00% 0.00% 1.01% 46.43%
Return On Investment Capital (ROIC_SIMPLE)
- - 5.48% 4.76%
Cost of Revenue to Revenue
7.08% -7.17% 10.78% -0.09%
SG&A Expenses to Revenue
41.81% 41.26% 32.73% 46.97%
R&D to Revenue
0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
42.28% 41.82% 33.97% 50.42%
Earnings before Interest and Taxes (EBIT)
364 607 524 478
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
368 610 527 489
Valuation Ratios
- - - -
Price to Book Value (P/BV)
0.00 0.00 9.34 10.52
Price to Tangible Book Value (P/TBV)
0.00 0.00 9.34 10.52
Price to Revenue (P/Rev)
0.00 0.00 1,184.00 359.45
Price to Earnings (P/E)
0.00 0.00 116.49 110.60
Dividend Yield
3.30% 3.80% 3.26% 2.96%
Earnings Yield
0.00% 0.00% 0.86% 0.90%
Enterprise Value to Invested Capital (EV/IC)
0.00 0.00 7.83 8.65
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 1,212.13 367.83
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 712.39 1,425.34
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 712.39 1,425.34
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 712.39 1,425.34
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 215.99 252.69
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 0.00
Leverage & Solvency
- - - -
Debt to Equity
0.00 0.00 0.02 0.07
Long-Term Debt to Equity
0.00 0.00 0.02 0.07
Financial Leverage
0.00 0.00 -0.05 -0.04
Leverage Ratio
0.00 0.00 1.37 1.46
Compound Leverage Factor
0.00 0.00 1.53 2.02
Debt to Total Capital
0.00% 0.00% 2.11% 6.31%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 0.00% 2.11% 6.31%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 21.60% 21.74%
Common Equity to Total Capital
0.00% 0.00% 76.29% 71.94%
Debt to EBITDA
0.00 0.00 2.06 11.61
Net Debt to EBITDA
0.00 0.00 -4.55 -7.52
Long-Term Debt to EBITDA
0.00 0.00 2.06 11.61
Debt to NOPAT
0.00 0.00 2.06 11.61
Net Debt to NOPAT
0.00 0.00 -4.55 -7.52
Long-Term Debt to NOPAT
0.00 0.00 2.06 11.61
Altman Z-Score
0.00 0.00 11.84 10.59
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 22.07% 23.21%
Liquidity Ratios
- - - -
Current Ratio
0.00 0.00 1.37 1.31
Quick Ratio
0.00 0.00 1.37 1.31
Cash Flow Metrics
- - - -
Free Cash Flow to Firm (FCFF)
0.00 0.00 -9,870 -10,077
Operating Cash Flow to CapEx
17,200.00% 316.94% 13,250.00% 37,800.00%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 0.00 0.00
Efficiency Ratios
- - - -
Asset Turnover
0.00 0.00 0.00 0.02
Accounts Receivable Turnover
0.00 0.00 0.02 0.06
Inventory Turnover
0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 0.00
Accounts Payable Turnover
0.00 0.00 0.02 0.03
Days Sales Outstanding (DSO)
0.00 0.00 20,875.82 5,766.41
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 21,303.37 10,623.09
Cash Conversion Cycle (CCC)
0.00 0.00 -427.54 -4,856.68
Capital & Investment Metrics
- - - -
Invested Capital
0.00 0.00 10,374 10,549
Invested Capital Turnover
0.00 0.00 0.01 0.05
Increase / (Decrease) in Invested Capital
0.00 0.00 10,374 10,549
Enterprise Value (EV)
0.00 0.00 81,213 91,222
Market Capitalization
16,785 15,227 79,328 89,143
Book Value per Share
$0.00 $0.00 $5.18 $5.25
Tangible Book Value per Share
$0.00 $0.00 $5.18 $5.25
Total Capital
0.00 0.00 11,128 11,773
Total Debt
0.00 0.00 235 743
Total Long-Term Debt
0.00 0.00 235 743
Net Debt
0.00 0.00 -519 -481
Capital Expenditures (CapEx)
3.00 124 2.00 1.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 0.00 797 571
Debt-free Net Working Capital (DFNWC)
0.00 0.00 1,129 1,051
Net Working Capital (NWC)
0.00 0.00 1,129 1,051
Net Nonoperating Expense (NNE)
-6.72 -60 -2.61 -112
Net Nonoperating Obligations (NNO)
0.00 0.00 -519 -481
Total Depreciation and Amortization (D&A)
4.00 3.00 3.00 11
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 1,189.55% 230.24%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 1,685.07% 423.79%
Net Working Capital to Revenue
0.00% 0.00% 1,685.07% 423.79%
Earnings Adjustments
- - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $0.00 $0.38
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 1.61B 1.61B
Adjusted Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.38
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 1.61B 1.63B
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 1.61B 1.61B
Normalized Net Operating Profit after Tax (NOPAT)
366 458 504 472
Normalized NOPAT Margin
42.54% 51.30% 48.13% 44.02%
Pre Tax Income Margin
51.57% 73.99% 55.53% 61.42%
Debt Service Ratios
- - - -
EBIT to Interest Expense
0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 0.00 0.00
Payout Ratios
- - - -
Dividend Payout Ratio
0.00% 0.00% 106.37% 103.78%
Augmented Payout Ratio
0.00% 0.00% 106.37% 103.78%

Key Financial Trends

Brookfield Asset Management Ltd. (BAM) has shown solid financial performance in Q1 2025 based on the latest available financials:

  • Consolidated net income for Q1 2025 rose to $507 million, up from $373 million in Q1 2024, indicating improved profitability.
  • Operating revenue increased from $861 million in Q1 2024 to approximately $1.05 billion in Q1 2025, showing strong top-line growth.
  • Gross profit improved significantly, with total gross profit reaching $935 million in Q1 2025 versus $800 million in Q1 2024, reflecting better operational efficiency.
  • Net cash from operating activities was positive at $265 million for Q1 2025, demonstrating effective cash generation despite some challenges in continuing operations.
  • Brookfield's total assets as of Q1 2025 were approximately $15 billion, supported by strong current and noncurrent assets, suggesting healthy financial resources.
  • Depreciation expense decreased slightly from $4 million in Q1 2024 to $3 million in Q1 2025, reflecting stable capital asset utilization.
  • The company recorded a net change in cash and equivalents of -$511 million in Q1 2025, indicating cash outflows in the period largely due to investing and financing activities.
  • Accounts receivable remain substantial at $3.83 billion in Q1 2025, signalling considerable outstanding revenues to be collected.
  • Weighted average shares outstanding remained steady at approximately 1.61 billion shares, implying no significant dilution during the recent quarter.
  • Net cash from continuing operating activities was negative $173 million in Q1 2025, despite strong net income, reflecting working capital and other operational cash flow challenges.
  • Cash payments for dividends stood at $710 million in Q1 2025, higher than the $622 million paid in Q1 2024, which may pressure cash reserves.
  • The balance sheet shows substantially lower total assets in Q1 2025 ($15 billion) compared to year-end 2024 ($490 billion for BN), indicating BAM and BN’s consolidation or classification differences that investors should watch closely.
  • Long-term debt as of Q1 2025 is $235 million, small compared to the $234.8 billion reported in BN’s year-end 2024 balance sheet, which could signal differences in reporting entities or capital structure changes.
  • Net cash from continuing financing activities was negative $422 million in Q1 2025, reflecting higher outflows potentially due to equity repurchases and dividend payments.

Summary: Brookfield Asset Management Ltd. shows robust income growth and improved profitability in early 2025, supported by higher revenues and gross profits. However, cash flow from continuing operations presents some concerns, as does increased dividend payout. Investors should note the substantial differences in total assets and liabilities between BAM’s Q1 2025 and BN’s year-end financials, likely reflecting reporting or accounting variations. Overall, the company is generating strong earnings but managing liquidity and capital allocation carefully going forward.

08/08/25 08:37 AMAI Generated. May Contain Errors.

Frequently Asked Questions About Brookfield's Financials

When does Brookfield's fiscal year end?

According to the most recent income statement we have on file, Brookfield's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Brookfield's net income changed over the last 8 years?

Brookfield's net income appears to be on a downward trend, with a most recent value of $541 million in 2024, falling from $3.34 billion in 2016. The previous period was $451 million in 2023. View Brookfield's forecast to see where analysts expect Brookfield to go next.

What is Brookfield's operating income?
Brookfield's total operating income in 2024 was -$29 million, based on the following breakdown:
  • Total Gross Profit: -$120 million
  • Total Operating Expenses: -$91 million
How has Brookfield's revenue changed over the last 8 years?

Over the last 8 years, Brookfield's total revenue changed from $24.41 billion in 2016 to -$120 million in 2024, a change of -100.5%.

How much debt does Brookfield have?

Brookfield's total liabilities were at $2.97 billion at the end of 2024, a 164.8% increase from 2023, and a 96.7% decrease since 2016.

How much cash does Brookfield have?

In the past 8 years, Brookfield's cash and equivalents has ranged from $0.00 in 2020 to $12.69 billion in 2021, and is currently $404 million as of their latest financial filing in 2024.

How has Brookfield's book value per share changed over the last 8 years?

Over the last 8 years, Brookfield's book value per share changed from 0.00 in 2016 to 7.86 in 2024, a change of 786.1%.



This page (NYSE:BN) was last updated on 8/8/2025 by MarketBeat.com Staff
From Our Partners